Enter multiple symbols separated by commas

Food and Staples Retailing Drug Retail


  • Aug 4- U.S. drugstore chain operator CVS Health Corp estimated current-quarter profit below analysts' expectations, hurt by pressure from reimbursement rates and lower customer traffic after the company stopped selling tobacco products. The company forecast adjusted profit of $1.27- $1.30 per share for the third quarter. The company also raised the lower...

  • *Walt Disney, Genworth to report after the bell. Aug 4- Wall Street was little changed on Tuesday amid a burst of earnings reports from companies ranging from drugstore operator CVS Health to handbag maker Coach, while Apple's shares remained under pressure for a second day. Among other companies scheduled to release results are Dow component Walt Disney, Devon...

  • Viagra shot? China probes sex drug-spiked liquor Sunday, 2 Aug 2015 | 8:38 PM ET
    Viagra pill

    Chinese police are investigating if two distillers added impotence treatment drug Viagra to their liquor in the latest food-safety scare in China.

  • Doctors fight to lower cancer drugs cost Friday, 24 Jul 2015 | 3:19 PM ET
    Doctors fight to lower cancer drugs cost

    Amid rising health care and drug costs, a group of doctors at the Mayo Clinic is trying to lower the costs of cancer treatments for patients. Insight, with Dr. Ayalew Tefferi, Mayo Clinic.

  • July 17- University of California Health, which runs four hospitals in the university's campuses, and drug retailer CVS Health Corp's CVSphoto.com became the latest victims of cyber attacks. UCLA Health said on Friday that data on as many as 4.5 million individuals was at potentially at risk, although it added it had not yet found evidence that individuals'...

  • What to expect from US June retail sales Monday, 13 Jul 2015 | 6:19 PM ET
    What to expect from US June retail sales

    Lindsey Bell, Senior Analyst at S&P Capital IQ, explains why she's expecting a monthly increase of 0.3 percent.

  • Euro zone leaders made Greece surrender much of its sovereignty to outside supervision in return for talks on an 86- billion-euro bailout to keep the near-bankrupt country within the single currency union. Drugstore chain CVS Health also came to market with a bond sale of up to $15 billion to finance its acquisitions of Omnicare and Target Pharmacies,...

  • July 9- Walgreens Boots Alliance Inc, the largest U.S. drug store chain, raised its full-year profit forecast on Thursday and said acting Chief Executive Officer Stefano Pessina will take over on a permanent basis. The company said it is on track to reach its target of at least $650 million net synergies in fiscal year 2015 from the merger and $1 billion in fiscal...

  • July 9- Drugstore chain Walgreens Boots Alliance Inc, formed by Walgreens' takeover of Europe's Alliance Boots in December, reported a better-than-expected quarterly profit, helped by higher prescription sales and lower costs. Walgreens Boots Alliance also bought Avon Products Inc's U.K.- based Liz Earle skincare business for 140 million pounds.

  • July 7- CVS Health Corp said it was withdrawing its membership from the U.S. Chamber of Commerce after media reports that the trade group was lobbying globally against anti-smoking laws. The No. 2 U.S. drugstore chain said it was "surprised" to read recent reports on the chamber's position on tobacco products outside the United States. The New York Times reported...

  • Rite Aid same-store sales miss estimates Thursday, 18 Jun 2015 | 7:16 AM ET

    June 18- Rite Aid Corp, the No.3 U.S. drugstore chain operator, reported slower-than-expected quarterly same-store sales growth as the introduction of new generic drugs hurt pharmacy sales. Net income more than halved to $18.8 million, or 2 cents per share, in the quarter, from $41.4 million, or 4 cents per share, a year earlier. The fall in net income was mainly due to...

  • June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses in a $1.9 billion deal that will help it bargain with drug makers for lower prices. "The addition of the Target pharmacy adds significant purchasing clout for pharmaceuticals," FBR Capital markets analyst Steven Halper wrote in a note.

  • June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses for about $1.9 billion to boost sales and prescription volumes. CVS's shares were up 0.4 percent at $102.65 in premarket trading on Monday, while Target's were flat at $79.50. Barclays is CVS's financial adviser, while Target's is Goldman Sachs.

  • Medical marijuana coming to New York state Monday, 15 Jun 2015 | 6:46 AM ET
    Medical marijuana coming to New York state

    New Yorkers suffering from cancer, epilepsy, Crohn's disease and Parkinson's disease may soon be able to access medical marijuana in the state. Jason Cranford, expert botanist and Director of Cultivation at the Compassionate Care Center of New York, provides insight.

  • New Alzheimer's drugs timeline Friday, 12 Jun 2015 | 1:05 PM ET
    New Alzheimer's drugs timeline

    How Alzheimer's drug Solanezumab works to help treat the underlying cause of the disease, with CNBC's Meg Tirrell.

  • The Fed's wholesale issue with Costco Friday, 5 Jun 2015 | 10:00 AM ET
    The Fed's wholesale issue with Costco

    Costco has been subpoenaed by the federal government concerning prescriptions for controlled substances.

  • Helping doctors share cancer research Tuesday, 2 Jun 2015 | 1:18 PM ET
    Helping doctors share cancer research

    CNBC's Meg Tirrell provides insight to what Foundation Medicine, a cancer testing company, can do to better inform doctors on cancer via a database filled with research.

  • Two parts of Express Scripts' new plan Wednesday, 27 May 2015 | 1:01 PM ET
    Two parts of Express Scripts' new plan

    A new plan for Express Scripts regarding cancer drugs, with CNBC's Meg Tirrell.

  • GHIT: A fund for neglected tropical diseases Tuesday, 19 May 2015 | 9:47 PM ET
    GHIT: A fund for neglected tropical diseases

    BT Slingsby, CEO of the Global Health Innovative Technology Fund (GHIT), explains why it is developing new innovative health technologies to combat diseases like tuberculosis and malaria.

  • Biotech to watch ahead of ASCO Wednesday, 13 May 2015 | 2:36 PM ET
    Biotech to watch ahead of ASCO

    The American Society of Clinical Oncology conference will occur at the end of May in Chicago. CNBC's Meg Tirrell reports which companies investors should watch. Also, Les Funtleyder, ESquared Asset Management, shares his view.